Suênia de Paiva Lacerda

Suênia de Paiva Lacerda

Auto-generated profile, based on publicly available information

Suênia de Paiva Lacerda

Université de Toulouse, France

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2011 in International Journal of Cosmetic Science
Verified
Journal Article
Closed access
PDF file
SLS. P. Lacerda
S. P. Lacerda
NCNatália Neto Pereira Cerize
Natália Neto Pereira Cerize
MRM. I. Ré
M. I. Ré

20 March 2015 in Drug Development and Industrial Pharmacy
Verified
Journal Article
Closed access
PDF file
SLSuênia de Paiva Lacerda
Suênia de Paiva Lacerda
FEFabienne Espitalier
Fabienne Espitalier
VHValérie Hoffart
Valérie Hoffart
MRMaria Inês Ré
Maria Inês Ré
This study concerns a new compound named CRS 74 which has the property of inhibiting Human Immunodeficiency Virus (HIV) protease, an essential enzyme involved in HIV replication process. It is proved in this study that the original CRS 74 exhibits poor aqueous solubility and a very low dissolution rate, which can influence its bioavailability and clinical response. In an attempt to improve the dissolution rate, CRS 74 was recrystallized by liquid anti-solvent (LAS) crystallization. Ethanol was chosen as solvent and water as the anti-solvent. Recrystallized solids were compared with the original drug crystals in terms of physical and dissolution properties. Recrystallization without additives did not modify the CRS 74 dissolution profile compared to the original drug. CRS 74 was then recrystallized using different additives to optimize the process and formulate physicochemical properties. Steric stabilizer in organic phase ensured size-controlling effect, whereas electrostatic stabilizer in aqueous phase decreased particle agglomeration. Cationic additives avoided drug adsorption onto stainless steel T-mixer. In general, additive improved drug dissolution rate due to improvement of wetting properties by specific interactions between the drug and the additives, and ensured continuous production of CRS 74 by electrostatic repulsion.

1 December 2016 in Brazilian Journal of Chemical Engineering
Verified
Journal Article
Open access
PDF file
SLS. P. Lacerda
S. P. Lacerda
JLJ. J. Letourneau
J. J. Letourneau
FEFabienne ESPITALIER
Fabienne ESPITALIER
MRM. I. Ré
M. I. Ré
This study concerns a new antiretroviral drug named CRS 74, which has a limited bioavailability because of its low aqueous solubility and dissolution rate. To improve these properties, CRS 74 can be recrystallized by using Liquid Anti-Solvent (LAS) crystallization. Ethanol is chosen as the solvent under study for the molecule and water as the anti-solvent. Since solubility data is limited, it is necessary to collect experimental data for the molecule in relation to ethanol and water-ethanol mixtures at different temperatures in order to select suitable mixture compositions and temperature for LAS process design. In this work, the CRS 74 solubility measured in the temperature range 288.15 - 303.15 K in pure ethanol and in 95% water - 5% w/w ethanol mixtures, and the CRS 74 solubility measured at 303.15 K in water-ethanol mixtures containing from 30 to 70% w/w ethanol are presented. Measurements were performed using the shake-flask method for generating the saturated solutions followed by compositional analysis by HPLC of the solution. The experimental data showed that the solubility of CRS 74 in binary hydroalcoholic mixtures increases upon increasing the temperature and mass fraction of ethanol. In order to better understand the behavior of the system and to estimate supersaturation conditions for a larger range of CRS 74 crystallization conditions, two models have been chosen to describe the experimental data: UNIQUAC and Jouyban-Acree models. The modeling of experimental solid-liquid equilibrium data proved that both models could correlate satisfactorily the solubility of the studied drug. This study provided valuable data for the recrystallization of CRS 74 by using the Liquid Anti-Solvent (LAS) crystallization process.

4 November 2026 in RSC Sustainability
Verified
Journal Article
Open access
LPLucie Perret
Lucie Perret
CACarole Antoine Assor
Carole Antoine Assor
JRJanet Reid
Janet Reid
SLSuênia De Paiva Lacerda
Suênia De Paiva Lacerda
MGMarie-Joo Le Guen
Marie-Joo Le Guen
Claire Mayer-LaigleClaire Mayer-Laigle
Claire Mayer-Laigle
This review aims at addressing the relation between extraction method, structure retention and gel function of polysaccharides.

31 March 2026
Verified
Thesis
Closed access
SLSuênia de Paiva Lacerda
Suênia de Paiva Lacerda
Improvement of dissolution rate of a new antiretroviral drug using an anti-solvent crystallization technology: Cette étude concerne une nouvelle molécule antirétrovirale nommée CRS 74. Cette molécule présente une biodisponibilité limitée à cause de sa faible solubilité en phase aqueuse, sa mauvaise mouillabilité et sa faible vitesse de dissolution. Afin d'améliorer sa biodisponibilité, la molécule CRS 74 a été recristallisée par effet anti-solvant. Le solvant choisi est l'éthanol et l'anti-solvant l'eau. L'équilibre solide-liquide dans des mélanges binaires éthanol/eau a été mesuré à 30°C. Les solubilités obtenues ont été représentées en utilisant le modèle UNIQUAC pour le calcul des coefficients d'activité. Les solubilités expérimentales et calculées ont permis d'évaluer le ratio éthanol/eau optimum (25/75 % m/m) pour maximiser le rendement théorique en solide. Un mélange double jet avec pré-mélangeur type mélangeur en T a été choisi pour réaliser la cristallisation. Le solide cristallisé dans ces conditions semble plus aggloméré et son profil de dissolution comparé à celui du solide initial est inchangé. De plus, l'étude des cristaux obtenus en sortie de pré-mélangeur a montré que les vitesses de croissance et d'agglomération des cristaux sont élevées. Des additifs ont donc été utilisés en vue de modifier les propriétés de dissolution des cristaux, et d'optimiser les paramètres de formulation et de cristallisation. Les microcristaux produits en présence d'additifs présentent des profils de dissolution significativement plus rapides que les cristaux de la molécule initiale. Cette modification est attribuable à la modification de taille des cristaux et l'amélioration du mouillage en raison des interactions spécifiques entre la surface des cristaux et les additifs.

17 February 2026 in Journal of Drug Delivery Science and Technology
Verified
Journal Article
Open access
VHVan-Trung-Tin Huynh
Van-Trung-Tin Huynh
JBJanine Boniatti
Janine Boniatti
SLSuênia de Paiva Lacerda
Suênia de Paiva Lacerda
MBMaëla Bernard
Maëla Bernard
SDSylvain Denis
Sylvain Denis
MRMaria-Inês Ré
Maria-Inês Ré